Cargando…

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

BACKGROUND/AIMS: To describe baseline characteristics and 12-month outcomes with vascular endothelial growth factor (VEGF) inhibitors of treatment-naïve hemiretinal vein occlusion (HRVO) compared with branch (BRVO) and central (CRVO) variants in routine clinical care. METHODS: A database observation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hunt, Adrian Robert, Nguyen, Vuong, Arnold, Jennifer J, McAllister, Ian L, Mehta, Hemal, Invernizzi, Alessandro, Ponsioen, Theodorus, Gabrielle, Pierre-Henry, O'Toole, Louise, Kusenda, Pavol, Alforja, Socorro, Barthelmes, Daniel, Gillies, Mark C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314087/ https://www.ncbi.nlm.nih.gov/pubmed/35078771 http://dx.doi.org/10.1136/bjophthalmol-2021-320482

Ejemplares similares

Hemiretinal Artery Occlusion in an 11-Year-Old Child with Dextrocardia
por: Arévalo Simental, Diana E., et al.
Publicado: (2016)

Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion
por: Bhandari, Sanjeeb, et al.
Publicado: (2022)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
por: Yalamanchi, Shalini, et al.
Publicado: (2011)

12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry
por: Niedzwiecki, Mateusz, et al.
Publicado: (2021)

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2‐year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry
por: Gabrielle, Pierre‐Henry, et al.
Publicado: (2021)

A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion
por: Ang, Juan Lyn, et al.
Publicado: (2020)

Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry
por: Nguyen, Vuong, et al.
Publicado: (2021)

Retinal capillary hemangioblastoma and hemiretinal vein occlusion in a patient with primary congenital glaucoma: A case report
por: AlBloushi, Abdulrahman F., et al.
Publicado: (2019)

Initial observation or treatment for diabetic macular oedema with good visual acuity: two‐year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry
por: Gabrielle, Pierre‐Henry, et al.
Publicado: (2020)

Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration
por: Teo, Kelvin Y. C., et al.
Publicado: (2022)

THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! Registry
por: Gabrielle, Pierre-Henry, et al.
Publicado: (2022)

Significant vision improvement and successful prevention of recurrence by electroacupuncture in hemiretinal vein occlusion combined with macular edema: A case report
por: Yan, Yan, et al.
Publicado: (2021)

Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis
por: Mehta, Hemal, et al.
Publicado: (2022)

ASSOCIATION BETWEEN ANATOMICAL AND CLINICAL OUTCOMES OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
por: Nguyen, Vuong, et al.
Publicado: (2021)

Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age‐related macular degeneration in daily clinical practice: data from the FRB! registry
por: Gabrielle, Pierre‐Henry, et al.
Publicado: (2022)

Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
por: Bhandari, Sanjeeb, et al.
Publicado: (2022)

Real‐world treatment outcomes of neovascular Age‐related Macular Degeneration in the Netherlands
por: Verbraak, Frank D., et al.
Publicado: (2020)

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis
por: Gabrielle, Pierre-Henry, et al.
Publicado: (2021)

Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema
por: Cornish, Elisa E, et al.
Publicado: (2023)

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
por: O’Day, Roderick, et al.
Publicado: (2013)

Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial
por: O’Day, Roderick F, et al.
Publicado: (2014)

Chorioretinal Anastomosis for Central Retinal Vein Occlusion: A Review of Its Development, Technique, Complications, and Role in Management
por: McAllister, Ian L.
Publicado: (2020)

Epimacular brachytherapy for wet AMD: current perspectives
por: Casaroli-Marano, Ricardo P, et al.
Publicado: (2014)

Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience
por: Debourdeau, Eloi, et al.
Publicado: (2023)

Metabolic and hormonal responses to a single session of kumite (free non-contact fight) and kata (highly ritualized fight) in karate athletes
por: Benedini, S., et al.
Publicado: (2012)

Systemic fungal infection in a dog: a unique case in Ireland
por: Atencia, Sabela, et al.
Publicado: (2014)

Addressing the unique needs of adolescent mothers in the fight against HIV
por: Groves, Allison K, et al.
Publicado: (2018)

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
por: Barthelmes, Daniel, et al.
Publicado: (2016)

Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence
por: Teo, Kelvin Yi Chong, et al.
Publicado: (2020)

Multimodal image characterization of paravenous atrophy
por: Alba-Linero, Carmen, et al.
Publicado: (2019)

Advancing Posttraumatic Stress Disorder Diagnosis and the Treatment of Trauma in Humanitarian Emergencies via Mobile Health: Protocol for a Proof-of-Concept Nonrandomized Controlled Trial
por: Pinto, Janaina V, et al.
Publicado: (2022)

Nitrofurans: Revival of an “old” drug class in the fight against antibiotic resistance
por: Le, Vuong Van Hung, et al.
Publicado: (2021)

Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
por: Abegg, Mathias, et al.
Publicado: (2008)

Two 11-Years Periods Statistics and Trends of Enucleation and Evisceration
por: Furdova, Alena, et al.
Publicado: (2021)

Unique Characteristics of the Pyrrolysine System in the 7th Order of Methanogens: Implications for the Evolution of a Genetic Code Expansion Cassette
por: Borrel, Guillaume, et al.
Publicado: (2014)

Corrigendum to “Unique Characteristics of the Pyrrolysine System in the 7th Order of Methanogens: Implications for the Evolution of a Genetic Code Expansion Cassette”
por: Borrel, Guillaume, et al.
Publicado: (2015)

Utility of adjunctive modalities in Coronary chronic total occlusion intervention
por: Bhatt, Hemal, et al.
Publicado: (2017)

A Case of Common Carotid Artery Occlusion: A Unique Pattern of Occlusion and Lessons Learned
por: Gunawardena, Thilina, et al.
Publicado: (2022)

Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry
por: Lawlor, Mitchell, et al.
Publicado: (2021)

Vessel Pulse Amplitude Mapping in Eyes With Central and Hemi Retinal Venous Occlusion
por: Khoo, Ying J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_demelu5fgqle8dqpmt0rbmu7t0